|Bid||36.300 x N/A|
|Ask||36.350 x N/A|
|Day's range||34.500 - 36.850|
|52-week range||22.550 - 40.900|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||26 Aug 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Terns Pharmaceuticals and Hansoh Pharma Announce Collaboration and License Agreement for TRN-000632 in Greater China
First paragraph, fourth sentence of the release should read: Hansoh will receive approximately $100 million in upfront payment and development and regulatory milestones, with additional undisclosed commercial milestones as well as royalty payments (instead of Hansoh will receive undisclosed upfront, regulatory and commercial milestone payments, as well as royalty payments).
With shares in Hansoh Pharmaceutical Co (HKG:3692) currently trading close to a 52 week high, a question many on the sidelines probably have is: quot;was I to...